Nippon India Pharma Fund - Direct Plan - Growth Plan
Add To Comparepreviously known as Reliance Pharma Dir Gr until
NAV on April 26, 2024
Category
Equity:
Sector - Healthcare
Sector - Healthcare
Investment StyleBox
Large Growth
Total Assets
7,125 cr
Turnover Ratio
18.67%
Expense Ratio
0.92%
Exit Load
1.00%
if redeemed within
Returns
- 1M: 1.20%
- 1Y: 54.49%
- 3M: 5.46%
- 3Y: 17.66%
- 6M: 27.84%
- 5Y: 23.77%
Best Sector Healthcare Funds
NAME | LATEST NAV |
RETURNS 1y |
FUND ASSETS |
Expense RATIO |
RISK | |
389.329 | 56.16% | 2,626 cr | 0.95% | - |
Other plans of Nippon India Pharma